5月6日讲座：Development of FGFR1-4 targeted therapeutics/Tyrosine kinase inhibitors: can we address?wild-type?receptor up-regulation
Title&Speaker:1. Development of FGFR1-4 targeted therapeutics
-- Prof. Jeff Smaill （University of Auckland）
2.Tyrosine kinase inhibitors: can we address wild-type?receptor up-regulation
--Dr. Adam Patterson（University of Auckland）
Venue: A201
Time: 5月6日（周二）, 10:15-11：45
Host:丁克 博士
